Details for New Drug Application (NDA): 011361
✉ Email this page to a colleague
NDA 011361 describes TRILAFON, which is a drug marketed by Schering and is included in five NDAs. Additional details are available on the TRILAFON profile page.
The generic ingredient in TRILAFON is perphenazine. There are eight drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the perphenazine profile page.
The generic ingredient in TRILAFON is perphenazine. There are eight drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the perphenazine profile page.
Summary for 011361
| Tradename: | TRILAFON |
| Applicant: | Schering |
| Ingredient: | perphenazine |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 011361
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET, EXTENDED RELEASE;ORAL | Strength | 8MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
